Published in Br J Clin Pharmacol on October 01, 1979
The role of presynaptic alpha-adrenoceptors in the regulation of blood pressure in the conscious rabbit. Br J Pharmacol (1982) 0.81
Coverage by the news media of the benefits and risks of medications. N Engl J Med (2000) 7.50
Resistance to -adrenoceptor stimulants (a possible explanation for the rise in ashtma deaths). Br J Pharmacol (1971) 6.11
Side effects of hypotensive agents evaluated by a self-administered questionnaire. Br Med J (1973) 5.65
Monitoring adverse reactions to drugs. Br Med J (1977) 4.41
Prognosis of treated hypertension. Changes in life expectancy and causes of death between 1952 and 1967. Q J Med (1970) 3.71
A symptom questionnaire for hypertensive patients. J Chronic Dis (1974) 3.51
Are Frozen Foods a Public Health Problem? Am J Public Health Nations Health (1947) 3.44
Isoprenaline resistance and the use of pressurised aerosols in asthma. Lancet (1968) 3.33
Comparison of cardiorespiratory effects of isoprenaline and salbutamol in patients with bronchial asthma. Br Med J (1970) 3.25
Clinical pharmacology and pharmacokinetics of clonidine. Clin Pharmacol Ther (1976) 3.13
Biomarkers of oxidative stress study II: are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning? Free Radic Biol Med (2005) 3.13
Cell-mediated immunity to Bordetella pertussis: role of Th1 cells in bacterial clearance in a murine respiratory infection model. Infect Immun (1993) 3.04
Hydralazine-induced systemic lupus erythematosus: influence of HLA-DR and sex on susceptibility. Lancet (1980) 2.63
Effect of propranolol in mild hypertension. Lancet (1966) 2.57
The Concise Guide to PHARMACOLOGY 2013/14: overview. Br J Pharmacol (2013) 2.48
Blood concentrations in man of fluorinated hydrocarbons after inhalation of pressurised aerosols. Lancet (1970) 2.48
Prostacyclin is not a circulating hormone in man. Prostaglandins (1982) 2.46
European journals, societies, and meetings. Meetings. Br Med J (1973) 2.46
Incidence of a positive direct coombs test in patients on alpha-methyldopa. Lancet (1966) 2.44
Isolation and enumeration of Listeria monocytogenes from Sewage, Sewage Sludge and River Water. J Appl Bacteriol (1981) 2.42
Effective immunization against Bordetella pertussis respiratory infection in mice is dependent on induction of cell-mediated immunity. Infect Immun (1993) 2.36
Attenuation of hypotensive effect of propranolol and thiazide diuretics by indomethacin. Br Med J (1980) 2.36
Clinical medicine and research in France. Br Med J (1973) 2.32
The role of the therapeutic alliance in psychotherapy and pharmacotherapy outcome: findings in the National Institute of Mental Health Treatment of Depression Collaborative Research Program. J Consult Clin Psychol (1996) 2.29
No evidence for lipid peroxidation in severe preeclampsia. Am J Obstet Gynecol (2001) 2.28
Effect of cysteinyl-leukotriene receptor antagonist ICI 204.219 on allergen-induced bronchoconstriction and airway hyperreactivity in atopic subjects. Lancet (1991) 2.27
Computer-based hypertension clinic records: a co-operative study. Br Med J (1974) 2.24
Intravenously administered isoproterenol sulfate dose-response curves in man. Arch Intern Med (1972) 2.23
Positive direct Coombs tests and antinuclear factor in patients treated with methyldopa. Lancet (1967) 2.22
Circulating catecholamines in exercise and hyperventilation induced asthma. Thorax (1981) 2.22
Randomised controlled trial of computer-held medical records in hypertensive patients. Br Med J (1976) 2.15
Change in symptoms of hypertensive patients after referral to hospital clinic. Br Heart J (1976) 2.13
The metabolic fate of DL(7-3H)isoprenaline in man and dog. Biochem J (1969) 2.06
Absorption and metabolism of nicotine from cigarettes. Br Med J (1975) 2.01
Clonidine withdrawal in hypertension. Changes in blood-pressure and plasma and urinary noradrenaline. Lancet (1977) 2.01
I. Ophthalmoscopic and circulatory changes in focal retinal ischaemia. Br J Ophthalmol (1966) 1.99
Pharmacokinetics of indoramin in man. Br J Clin Pharmacol (1976) 1.97
Anaphylactoid reactions to i.v. substances. Br J Anaesth (1979) 1.93
Syst-Eur. A multicentre trial on the treatment of isolated systolic hypertension in the elderly: objectives, protocol, and organization. Aging (Milano) (1991) 1.93
Suxamethonium anaphylaxis. Lancet (1989) 1.93
Clinical pharmacology of beta-receptor-blocking drugs. Clin Pharmacol Ther (1970) 1.92
Pharmacokinetics and concentration-effect relationships of intervenous and oral clonidine. Clin Pharmacol Ther (1977) 1.91
Increased F2-isoprostanes in Alzheimer's disease: evidence for enhanced lipid peroxidation in vivo. FASEB J (1998) 1.89
Assessment of selective beta-adrenoceptor blockade in man. Br J Pharmacol (1973) 1.85
Pathogenesis of hypertensive retinopathy. An experimental study in the monkey. Br J Ophthalmol (1975) 1.79
Rifampicin and vitamin D metabolism. Clin Pharmacol Ther (1980) 1.78
Clinical evaluation of indoramin, a new antihypertensive agent. Eur J Clin Pharmacol (1973) 1.78
Minoxidil in resistant hypertension. Lancet (1977) 1.77
Identification and quantitation of hypersensitivity reactions to intravenous anaesthetic agents. Br J Anaesth (1976) 1.76
Nicotine effects on eicosanoid formation and hemostatic function: comparison of transdermal nicotine and cigarette smoking. J Am Coll Cardiol (1993) 1.76
Cytochrome composition and effect of catalase on growth of Agromyces ramnosus. Nature (1970) 1.75
The drug treatment of hypertension. Practitioner (1971) 1.75
Glucose intolerance in hypertensive patients treated with diuretics; a fourteen-year follow-up. Lancet (1982) 1.73
Experimental retinal branch vein occlusion. Am J Ophthalmol (1970) 1.72
Role of nifedipine in treatment of hypertension. Br Med J (Clin Res Ed) (1983) 1.70
Local inhibition of converting enzyme and vascular responses to angiotensin and bradykinin in the human forearm. J Physiol (1989) 1.68
Urinary leukotriene E4 after antigen challenge and in acute asthma and allergic rhinitis. Lancet (1989) 1.66
Prostaglandin D2 potentiates airway responsiveness to histamine and methacholine. Am Rev Respir Dis (1986) 1.65
Serum-insulin in essential hypertension and in peripheral vascular disease. Lancet (1966) 1.61
Brain metabolism in teenagers with attention-deficit hyperactivity disorder. Arch Gen Psychiatry (1993) 1.60
Medical students in general practice: how do patients feel? Br J Gen Pract (1996) 1.59
Editorial: Pharmacokinetics--master or servant? Eur J Clin Pharmacol (1973) 1.57
Brain concentration of propranolol in relation to hypotensive effect in the rabbit with observations on brain propranolol levels in man. J Pharmacol Exp Ther (1975) 1.56
Clinical pharmacology of beta-reccer-atefoygolocarahp lnilcc clinical pharmacology of beta-receptor-blocking drugs. Clin Pharmacol Ther (1969) 1.56
Immune-mediated reactions to althesin (alphaxalone). Br J Anaesth (1976) 1.56
Radiology report times: impact of picture archiving and communication systems. AJR Am J Roentgenol (1998) 1.55
Effect of oral prednisone on airway inflammatory mediators in atopic asthma. Am J Respir Crit Care Med (1994) 1.54
Human platelet/erythroleukemia cell prostaglandin G/H synthase: cDNA cloning, expression, and gene chromosomal assignment. FASEB J (1991) 1.54
Psychopathology in people with epilepsy and intellectual disability; an investigation of potential explanatory variables. J Neurol Neurosurg Psychiatry (2003) 1.53
Alveolar gas concentrations of fluorocarbons-11 and-12 in man after use of pressurized aerosols. Thorax (1974) 1.52
Health state utilities for metastatic breast cancer. Br J Cancer (2006) 1.50
Heparin kinetics in venous thrombosis and pulmonary embolism. Circulation (1976) 1.50
Long-term antihypertensive drug treatment and blood pressure control in three hospital hypertension clinics. Br Heart J (1980) 1.49
Measurement of 6-oxo-PGF1 alpha in human plasma using gas chromatography-mass spectrometry. Prostaglandins (1979) 1.48
Adverse reactions to intravenous anaesthetic induction agents. Br Med J (1977) 1.47
Increased pulmonary alpha-adrenergic and reduced beta-adrenergic receptors in experimental asthma. Nature (1980) 1.46
Measurement of plasma histamine in asthma. Clin Allergy (1983) 1.46
Effect of enalapril on the skin response to bradykinin in man. Br J Clin Pharmacol (1987) 1.46
Central hypotensive effect of propranolol in the rabbit. Br J Pharmacol (1973) 1.44
Surgical treatment of emphysema. Br Med J (1966) 1.44
The importance of central adrenergic neurones in renal hypertension in rabbits. J Physiol (1974) 1.43
Increased sensitivity and accuracy of phaeochromocytoma diagnosis achieved by use of plasma-adrenaline estimations and a pentolinium-suppression test. Lancet (1981) 1.42
Biomarkers of oxidative stress study III. Effects of the nonsteroidal anti-inflammatory agents indomethacin and meclofenamic acid on measurements of oxidative products of lipids in CCl4 poisoning. Free Radic Biol Med (2005) 1.42
Hypertension in the young. Q J Med (1967) 1.42
Cerebral mass lesions in patients with AIDS. BMJ (1990) 1.40
An academy of medicine: a future for British postgraduate medicine? Br J Hosp Med (1995) 1.39
AIDS--preventing a pandemic. J R Coll Gen Pract (1986) 1.39
Screening for antibodies to anesthetics. BMJ (1989) 1.39
A case for co-ordinated investigation and reporting of hypersensitivity-type drug reactions in the UK. Anaesthesia (2000) 1.39
Immunological characterization of urinary 8-epi-prostaglandin F2 alpha excretion in man. J Pharmacol Exp Ther (1995) 1.38
Atenolol in essential hypertension. Clin Pharmacol Ther (1976) 1.38
Metabolism of isoprenaline in dog and man. Br J Pharmacol (1972) 1.38
Skin testing and the anaesthetist. Br J Anaesth (2000) 1.38
Effect of raised intraocular pressure on the retinal and choroidal circulation. Invest Ophthalmol (1968) 1.38
Drug concentration in saliva. Clin Pharmacol Ther (1978) 1.38